Published in J Immunol on May 01, 1975
Transcriptional and posttranscriptional modulation of myeloid colony-stimulating factor expression by tumor necrosis factor and other agents. Mol Cell Biol (1988) 1.27
Use of mice tolerant to lipopolysaccharide to demonstrate requirement of cooperation between macrophages and lymphocytes to generate lipopolysaccharide-induced colony-stimulating factor in vivo. Infect Immun (1983) 1.11
Polycythemia vera. Increased expression of normal committed granulocytic stem cells in vitro after exposure of marrow to tritiated thymidine. J Clin Invest (1979) 0.98
Endotoxin-associated protein: a potent stimulus for human granulocytopoietic activity which may be accessory cell independent. Infect Immun (1988) 0.81
Factors influencing in vitro production of colony-stimulating factor by mononuclear leukocytes from humans. Can Med Assoc J (1979) 0.75
Pathology-important advances in clinical medicine: assessing fetal lung maturity. West J Med (1984) 0.75
Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A (1980) 30.08
Selective in vitro growth of T lymphocytes from normal human bone marrows. Science (1976) 15.73
Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl Acad Sci U S A (1978) 9.59
Functional and morphologic characterization of human T cells continuously grown in vitro. J Immunol (1977) 6.30
Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J Immunol (1991) 5.02
Characterization of the reverse transcriptase from a new retrovirus (HTLV) produced by a human cutaneous T-cell lymphoma cell line. Virology (1981) 4.68
Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sézary T-cell leukaemia. Nature (1981) 4.38
Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells. J Immunol (1981) 4.27
Characterization and distribution of nucleic acid sequences of a novel type C retrovirus isolated from neoplastic human T lymphocytes. Proc Natl Acad Sci U S A (1981) 4.24
Long-term culture of human antigen-specific cytotoxic T-cell lines. J Exp Med (1978) 3.80
Quantitative studies of blood and bone marrow neutrophils in normal mice. Am J Physiol (1968) 3.33
Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factor. J Exp Med (1981) 3.30
T-cell growth factor-mediated T-cell proliferation. Ann N Y Acad Sci (1979) 3.16
T-cell lines established from human T-lymphocytic neoplasias by direct response to T-cell growth factor. Proc Natl Acad Sci U S A (1980) 2.89
Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide. J Exp Med (1979) 2.80
Immunological properties of a type C retrovirus isolated from cultured human T-lymphoma cells and comparison to other mammalian retroviruses. J Virol (1981) 2.72
Human T-lymphocyte growth factor: regulation of growth and function of T lymphocytes. Blood (1981) 2.58
Detection of the human T cell lymphoma virus p19 in cells of some patients with cutaneous T cell lymphoma and leukemia using a monoclonal antibody. J Exp Med (1981) 2.47
Human blood monocytes: stimulators of granulocyte and mononuclear colony formation in vitro. Science (1972) 2.21
T-cell growth factor and the culture of cloned functional T cells. Adv Immunol (1981) 2.09
Human immunodeficiency virus type 1-neutralizing monoclonal antibodies which react with p17 core protein: characterization and epitope mapping. J Virol (1989) 2.00
Natural antibodies to the human T cell lymphoma virus in patients with cutaneous T cell lymphomas. J Exp Med (1981) 1.84
In vitro growth of granulocytic and mononuclear cell colonies from blood of normal individuals. Blood (1971) 1.74
Functional and molecular characteristics of T-cell growth factor. Mol Immunol (1980) 1.66
Induction of CD4+ T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-beta. J Immunol (1999) 1.61
Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. J Clin Invest (1998) 1.61
Immortalized hemopoietic cells with stem cell properties. Immunity (1994) 1.55
Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action. J Exp Med (1990) 1.51
Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFN-gamma) promoter and subsequent downregulation of IFN-gamma production. Mol Cell Biol (1998) 1.48
Bone marrow colonies: stimulation in vitro by supernatant from incubated human blood cells. Science (1970) 1.44
Specific release of neutrophillic- and eosinophilic-stimulating factors from sensitized lymphocytes. Blood (1976) 1.43
Octapeptides deduced from the neuropeptide receptor-like pattern of antigen T4 in brain potently inhibit human immunodeficiency virus receptor binding and T-cell infectivity. Proc Natl Acad Sci U S A (1986) 1.43
Inhibition of early murine hemopoietic progenitor cell proliferation after in vivo locoregional administration of transforming growth factor-beta 1. J Immunol (1989) 1.39
Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells. J Immunol (1986) 1.37
Release of colony-stimulating activity from thymus-derived lymphocytes. J Clin Invest (1975) 1.37
Human T-cell leukemia-lymphoma virus (HTLV) is in T but not B lymphocytes from a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A (1982) 1.37
Decreased neutrophils and megakaryocytes in anemic mice of genotype W/W. J Cell Physiol (1969) 1.34
Detection of HLA-DRw (Ia-like) antigens on human T lymphocytes grown in tissue culture. J Immunol (1979) 1.33
Transforming growth factor beta 1 directly and reversibly inhibits the initial cell divisions of long-term repopulating hematopoietic stem cells. Blood (1996) 1.32
Macrophage inflammatory protein (MIP)-1 beta abrogates the capacity of MIP-1 alpha to suppress myeloid progenitor cell growth. J Immunol (1991) 1.32
Mechanistic studies of transforming growth factor-beta inhibition of IL-2-dependent activation of CD3- large granular lymphocyte functions. Regulation of IL-2R beta (p75) signal transduction. J Immunol (1991) 1.31
Activation of infectious virus from latent human immunodeficiency virus infection of monocytes in vivo. J Clin Invest (1992) 1.29
Functional characterization of a novel hematopoietic stem cell and its place in the c-Kit maturation pathway in bone marrow cell development. Immunity (1999) 1.28
Human T-cell leukemia virus type I infection of monocytes and microglial cells in primary human cultures. Proc Natl Acad Sci U S A (1992) 1.24
Transforming growth factor beta 1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell lines. J Exp Med (1988) 1.24
Infection of lymphoid cells by integration-defective human immunodeficiency virus type 1 increases de novo methylation. J Virol (2001) 1.23
Human leukemic cells: in vitro growth of colonies containing the Philadelphia (Ph) chromosome. Science (1971) 1.20
Transforming growth factor beta selectively inhibits normal and leukemic human bone marrow cell growth in vitro. Blood (1988) 1.18
A familialdefect in platelet function associated with imapired release of adenosine diphosphate. N Engl J Med (1969) 1.18
Negative regulation of human immune deficiency virus replication in monocytes. Distinctions between restricted and latent expression in THP-1 cells. J Exp Med (1990) 1.18
Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry. Biochem Biophys Res Commun (2000) 1.16
Transcriptional regulation of the transforming growth factor beta 1 promoter by v-src gene products is mediated through the AP-1 complex. Mol Cell Biol (1990) 1.11
Association of protein kinase C activation with IL 2 receptor expression. J Immunol (1986) 1.11
Formation of fetal rat cardiac cell clones by retroviral transformation: retention of select myocyte characteristics. J Mol Cell Cardiol (1993) 1.10
Release of colony-stimulating factor from monocytes by endotoxin and polyinosinic-polycytidylic acid. J Lab Clin Med (1974) 1.10
Tumor necrosis factor alpha directly and indirectly regulates hematopoietic progenitor cell proliferation: role of colony-stimulating factor receptor modulation. J Exp Med (1992) 1.10
Gamma-interferon-induced activation of latent transforming growth factor-beta by human monocytes. Ann N Y Acad Sci (1990) 1.08
Effect of endotoxin and postendotoxin plasma on in vitro granulopoiesis. J Lab Clin Med (1972) 1.08
Transforming growth factor beta directly regulates primitive murine hematopoietic cell proliferation. Blood (1990) 1.05
BP1, a new homeobox gene, is frequently expressed in acute leukemias. Leukemia (2000) 1.05
JAK2 is associated with the c-kit proto-oncogene product and is phosphorylated in response to stem cell factor. Blood (1996) 1.05
Infectious mononucleosis. Dis Mon (1974) 1.04
Two forms of transforming growth factor-beta are equally potent selective growth inhibitors of early murine hematopoiesis. Ann N Y Acad Sci (1990) 1.04
Identification and characterization of a human T cell line-derived lymphokine with MAF-like activity distinct from interferon-gamma. J Immunol (1986) 1.04
Preferential suppression of myelopoiesis in normal human bone marrow cells after in vitro challenge with human cytomegalovirus. Blood (1990) 1.04
Extracellular human T-cell lymphotropic virus type I Tax protein induces cytokine production in adult human microglial cells. Ann Neurol (1994) 1.03
Induction of differentiation of HL-60 cells by dimethyl sulfoxide: evidence for a stochastic model not linked to the cell division cycle. Cancer Res (1982) 1.03
Transforming growth factor-beta 1 in heart development. Mech Dev (1992) 1.02
Accumulation of 70S monoribosomes in Escherichia coli after energy source shift-down. J Bacteriol (1972) 1.01
Factors influencing hematopoietic spleen colony formation in irradiated mice. II. The effect of foreign materials. J Exp Med (1967) 1.01
Detection of human T-cell leukemia/lymphoma virus, type II, in a patient with large granular lymphocyte leukemia. Blood (1992) 1.01
Factors influencing hematopoietic spleen colony formation in irradiated mice. 3. The effect of repetitive irradiation upon proliferative ability of colony-forming cells. J Exp Med (1967) 1.01
A biochemical variant of human T cell growth factor produced by a cutaneous T cell lymphoma cell line. J Immunol (1982) 1.01
Serum reactivity to human T-cell leukaemia/lymphoma virus type I proteins in patients with large granular lymphocytic leukaemia. Lancet (1987) 1.01
Regulation of expression of the interleukin-2 receptor on hematopoietic cells by interleukin-3. Science (1986) 0.99
Corneal toxicity with systemic cytarabine. Am J Ophthalmol (1981) 0.98
IL-1 alpha induces expression of active transforming growth factor-beta in nonproliferating T cells via a post-transcriptional mechanism. J Immunol (1990) 0.97
Administration of recombinant human interleukin-7 alters the frequency and number of myeloid progenitor cells in the bone marrow and spleen of mice. Blood (1992) 0.97
Factors influencing hematopoietic spleen colony formation in irradiated mice. VI. The different effects of foreign plasma, endotoxin, and bleeding on colony-forming cell kinetics. Radiat Res (1968) 0.97
In vitro infection of primary and retrovirus-infected human leukocytes by human foamy virus. J Virol (1996) 0.96
Human T-cell growth factor: parameters for production. J Supramol Struct (1980) 0.96
Stimulation of granulopoiesis by transforming growth factor beta: synergy with granulocyte/macrophage-colony-stimulating factor. Proc Natl Acad Sci U S A (1991) 0.96
Steel factor (c-kit ligand) promotes the survival of hematopoietic stem/progenitor cells in the absence of cell division. Blood (1995) 0.96
The synthetic peptide WKYMVm attenuates the function of the chemokine receptors CCR5 and CXCR4 through activation of formyl peptide receptor-like 1. Blood (2001) 0.96
Isolation of LAV/HTLV-III from a patient with amyotrophic lateral sclerosis. N Engl J Med (1985) 0.96
Persistent in vitro infection by human T-cell leukemia-lymphoma virus (HTLV) of normal human T-lymphocytes from blood relatives of patients with HTLV-associated mature T-cell neoplasms. Int J Cancer (1983) 0.95
Vitamin E succinate induces Fas-mediated apoptosis in estrogen receptor-negative human breast cancer cells. Cancer Res (1997) 0.95
Interleukin-1 (IL-1) directly and indirectly promotes hematopoietic cell growth through type I IL-1 receptor. Blood (1994) 0.94
Transforming growth factor beta: possible roles in the regulation of normal and leukemic hematopoietic cell growth. J Cell Biochem (1989) 0.94
Differential expression of Rel family members in human T-cell leukemia virus type I-infected cells: transcriptional activation of c-rel by Tax protein. J Virol (1993) 0.93
Granulocytopoiesis in germfree mice. Proc Soc Exp Biol Med (1967) 0.93
Negative regulation of human immunodeficiency virus type 1 expression in monocytes: role of the 65-kDa plus 50-kDa NF-kappa B dimer. Proc Natl Acad Sci U S A (1991) 0.93
Increase in circulating stem cells in patients with myelofibrosis. Blood (1973) 0.92
Recombinant transforming growth factor beta 1 and beta 2 protect mice from acutely lethal doses of 5-fluorouracil and doxorubicin. J Exp Med (1994) 0.92
Growth inhibition of a human lymphoma cell line: induction of a transforming growth factor-beta-mediated autocrine negative loop by phorbol myristate acetate. Cell Growth Differ (1990) 0.92
Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: increased binding of cyclin A negatively regulates E2F transactivation activity. Cancer Res (1997) 0.91